Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literaturverzeichnis
Antoni H, Herkel K, Fleckenstein A (1963) Die Restitution der automatischen Erregungsbildung in Kalium-gelähmten Schrittmacher-Geweben durch Adrenalin - Elektrophysiologische Studien am isolierten Sinusknoten (Meerschweinchen, Rhesusaffe) sowie am Purkinje-Faden (Rhesusaffe). Pflugers Arch 277: 633–649
Antoni H, Oberdisse E (1965) Elektrophysiologische Untersuchungen über die Barium-induzierte Schrittmacher-Aktivität im isolierten Säugetiermyokard. Pflugers Arch 284: 259–272
Beck OA, Witt E, Lehmann H-U, Hochrein H (1978) Die Wirkung von Gallopamil (D600) auf die intrakardiale Erregungsleitung und Sinusknotenautomatie beim Menschen. Z Kardiol 67: 522–526
Bender F (1967) Isoptin zur Behandlung der tachykarden Form des Vorhofflatterns. Med Klin 62: 634–636
Byon YK, Fleckenstein A (1969) Parallele Beeinflussung von isometrischer Spannungsentwicklung und O2-Verbrauch isolierter Papillarmuskeln unter dem Einfluß von Ca+ +-Ionen, Adrenalin, Isoproterenol, und organischen Ca+ +-Antagonisten (Iproveratril, D600, Prenylamin). Pflugers Arch 312: R 8/9
Cranefield PF (1975) The conduction of the cardiac impulse - The slow response and cardiac arrhythmias. Futura, New York
Dargie H, Rowland E, Krikler D (1981) Role of calcium antagonists in cardiovascular therapy. Br Heart J 46: 8–16
Fleckenstein A (1964) Die Bedeutung der energiereichen Phosphate für Kontraktilität und Tonus des Myokards. Verh Dtsch Ges Inn Med (70th Congr) 81–99
Fleckenstein A (1968 a) Experimentelle Pathologie der akuten und chronischen Herzinsuffizienz. Verh Dtsch Ges Herz Kreislaufforsch 34: 15–34
Fleckenstein A (1968 b) Experimental heart failure due to disturbances in high-energy phosphate metabolism. Proc Vth Eur Congr Cardiol Athens (Sept 1968) 255–269
Fleckenstein A (1968c) Myocardstoffwechsel und Nekrose. In: Heilmeyer L, Holtmeier HJ (Hrsg) VI. Symposium der Deutsch. Ges. für Fortschritte auf dem Gebiet der Inneren Medizin über Herzinfarkt und Schock, 8. Nov. 1968 in Freiburg. Thieme, Stuttgart, S 94-109
Fleckenstein A (1970) Die Zügelung des Myokardstoffwechsels durch Verapamil. Angriffspunkte und Anwendungsmöglichkeiten. Arzneimittelforsch 20: 1317–1322
Fleckenstein A (1970/71) Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Harris P, Opie L (eds) Calcium and the Heart, Proceedings of the Meeting of the European Section of the International Study Group for Research in Cardiac Metabolism, London, Sept. 6, 1970. Academic Press, London New York, pp 135-188
Fleckenstein A (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol 17: 149–166
Fleckenstein A (1978/80) Steuerung der myocardialen Kontraktilität, ATP-Spaltung, Atmungsintensität und Schrittmacher-Funktion durch Calcium-Ionen - Wirkungsmechanismus der Calcium-Antagonisten. In: Fleckenstein A, Roskamm (Hrsg) Calcium-Antagonismus, Proceed. of an Internat. Symp. 1978 in Frankfurt. Springer, Berlin Heidelberg New York, S 1–28
Fleckenstein A (1980/81) Pharmacology and electrophysiology of calcium-antagonists. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy: Experience with Verapamil, Internat. Symp. in Florence, 2–4 October 1980. Excerpta Medica, Amsterdam Oxford Princeton, pp 10-29
Fleckenstein A (1983) Calcium-antagonism in heart and smooth muscle - Experimental facts, therapeutic prospects. John Wiley, New York
Fleckenstein A, Döring HJ, Janke J, Byon YK (1975) Basic actions of ions and drugs on myocardial high-energy phosphate metabolism and contractility. In: Schmier J, Eichler O (eds) Handbook of experimental pharmacology, New Series, vol XVI/3. Springer, Berlin Heidelberg New York, pp 345–405
Fleckenstein A, Döring JH, Leder O (1969 b) The significance of high-energy phosphate exhaustion in the etiology of isoproterenol-induced cardiac necrosis and its prevention by iproveratril, compound D600 or prenylamine. In: Lamarche M, Royer R (eds) International Symposium on Drugs and Metabolism of Myocardium and Striated Muscle, Nancy, pp 11–22
Fleckenstein A, Fleckenstein-Grün G (1980) Cardiovascular protection by Ca antagonists. Eur Heart J 1: [Suppl B] 15–21
Fleckenstein A, Fleckenstein-Grün G, Byon YK (1977) Fundamentale Herz- und Gefäßwirkungen des Ca+ +-antagonistischen Koronartherapeutikums Fendilin (Sensit)R. Arzneimittelforsch 27: 562–571
Fleckenstein A, Fleckenstein-Grün G, Byon YK, Haastert HP, Späh F (1979) Vergleichende Untersuchungen über die Ca+ +-antagonistischen Grundwirkungen von Niludipin (Bay a 7168) und Nifedipin (Bay a 1040) auf Myokard, Myometrium und glatte Gefäßmuskulatur. Arzneimittelforsch 29: 230–246
Fleckenstein A, Grün G, Byon YK, Döring HJ, Tritthart H (1973/75) The basic Ca-antagonistic actions of nifedipine on cardiac energy metabolism and vascular smooth muscle tone. In: Hashimoto K, Kimura E, Kobayashi T (eds). New therapy of ischemic heart disease. 1st Internat Adalat Symp. in Tokyo, 1973, University of Tokyo Press, pp 31–44
Fleckenstein A, Janke J, Döring JH, Leder O (1971) Die intracelluläre Überladung mit Kalzium als entscheidender Kausalfaktor bei der Entstehung nicht-coronarogener Myokard-Nekrosen. Verh Dtsch Ges Kreislaufforsch 37: 345–353
Fleckenstein A, Janke J, Döring HJ, Leder O (1974) Myocardial fiber necrosis due to intracellular Ca overload - a new principle in cardiac pathophysiology. In: Dhalla NS (ed) Myocardial biology, recent advances in studies on cardiac structure and metabolism, vol 4. University Park Press, Baltimore London Tokyo, pp 563–58031
Fleckenstein A, Janke J, Döring HJ, Leder O (1975) Key role of Ca in the production of noncoronarogenic myocardial necroses. In: Fleckenstein A, Rona G (eds) Pathophysiology and morphology of myocardial cell alterations, recent advances in studies on cardiac structure and metabolism vol 6. University Park Press, Baltimore London Tokyo, pp 21–32
Fleckenstein A, Janke J, Döring HJ, Pachinger O (1973) Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions. In: Bajusz E, Rona G (eds) Cardiomyopathies, recent advances in studies on cardiac structure and metabolism, vol 2. University Park Press, Baltimore London Tokyo, pp 455–466
Fleckenstein A, Kammermeier H, Döring HJ, Freund HJ (1967) Zum Wirkungsmechanismus neuartiger Koronardilatatoren mit gleichzeitig Sauerstoff-einsparenden Myokard-Effekten, Prenylamin und Irpoveratril. Z Kreislaufforsch 56: 716–744, 839–853
Fleckenstein A, Späh F (1981/82) Excitation-contraction uncoupling in cardiac muscle. In: Yoshida H, Hagihara Y, Ebashi S (eds) Advances in pharmacology and therapeutics II, vol 3: Cardio-renal and cell pharmacology, Proceed. 8th Internat. Pharmacological Congress, Tokyo, July, 1981. Pergamon, Oxford New York, pp 97–110
Fleckenstein A, Tritthart H, Döring HJ, Byon YK (1972) Bay a 1040 - ein hochaktiver Ca+ +-antagonistischer Inhibitor der elektro-mechanischen Koppelungsprozesse im Warmblüter-Myokard. Arzneimittelforsch 22: 22–33
Fleckenstein A, Tritthart H, Fleckenstein B, Herbst A, Grün G (1969a) A new group of competitive Ca-antagonists (Iproveratril, D 600, Prenylamine) with highly potent inhibitory effects on excitationcontraction coupling in mammalian myocardium. Pflugers Arch 307: R25
Fleckenstein B (1970) Selektive Zügelung der Myocard-Kontraktilität durch Ca+ +-antagonistische Hemmstoffe der elektro-mechanischen Koppelung. Med. Dissertation, Universität Freiburg
Fleckenstein-Grün G, Fleckenstein A, Byon YK, Kim KW (1976/78) Mechanism of action of Ca+ +-antagonists in the treatment of coronary disease with special reference to perhexiline maleate. Proceed. Symp. on Perhexiline Maleate, Sept. 18, 1976 in Strasbourg. Excerpta Medica, Amsterdam, pp 1–22
Garvey HL (1969) The mechanism of action of verapamil on the sinus and AV nodes. Eur J Pharmacol 8: 159–166
Haastert HP, Fleckenstein A (1975) Ca-dependence of supraventricular pacemaker activity and its responsiveness to Ca-antagonistic compounds (verapamil, D 600, nifedipine). Naunyn Schmiedebergs Arch Pharmacol [Suppl] 287: R39
Henry PD, Shuchleib R, Borda LJ, Roberts R, Williamson JR, Sobel BE (1978) Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res 43: 372–380
Jasmin G, Bajusz E (1975) Prevention of myocardial degeneration in hamsters with hereditary cardiomyopathy. In: Fleckenstein A, Rona G (eds) Recent advances in studies on cardiac structure and metabolism, vol 6. University Park Press, Baltimore London Tokyo, pp 219–229
Jasmin G, Proscheck L (1980) Prevention of myocardial degeneration in hamsters with hereditary cardiomyopathy. Fleckenstein A, Roskamm H (eds) Calcium-Antagonismus. Springer, Berlin Heidelberg New York, pp 144–150
Jasmin G, Solymoss B (1975) Prevention of hereditary cardiomyopathy in the hamster by verapamil and other agents (38771). Proc Soc Exp Biol Med 149: 193–198
Kass RS, Tsien RW (1975) Multiple effects of calcium antagonists on plateau currents in cardiac Purkinje fibres. J Gen Physiol 66: 169–192
Kohlhardt M, Bauer B, Krause H, Fleckenstein A (1972) Differentiation of the transmembrane Na and Ca channel in mammalian cardiac fibres by the use of specific inhibitors. Pflugers Arch 335: 309–322
Kohlhardt M, Figulla HR, Tripathi O (1976) The slow membrane channel as the predominant mediator of the excitation process of the sinoatrial pacemaker cell. Basic Res Cardiol 71: 17–26
Krikler DM, Spurrell RAJ (1974) Verapamil in the treatment of paroxysmal supraventricular tachykardia. Postgrad Med 50: 447–453
Landmark K, Amilie JP (1976) A study of the verapamil-induced changes in conductivity and refractoriness and monophasic action potentials of the dog heart in situ. Eur J Cardiol 4: 419–427
Lossnitzer K, Janke J, Hein B, Stauch M, Fleckenstein A (1975) Disturbed myocardial calcium metabolism: A possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster. In: Fleckenstein A, Rona G (eds) Recent advances in studies on cardiac structure and metabolism, vol 6. University Park Press, Baltimore London Tokyo, pp 207–217
Lossnitzer K, Konrad A, Jakob M (1980) Kardioprotektion durch Kalzium-Antagonisten bei erblich kardiomyopathischen Hamstern. In: Fleckenstein A, Roskamm H (Hrsg) Calcium-Antagonismus. Springer, Berlin Heidelberg New York, S151–171
Lupi GA, Urthaler F, James TN (1979) Effects of verapamil on automaticity and conduction with particular reference to tachyphylaxis. Eur J Cardiol 9: 345–368
Mascher D (1970) Electrical and mechanical responses from ventricular muscle fibres after inactivation of the sodium carrying system. Pflugers Arch 317: 359–372
Mascher D, Peper K (1969) Two components of inward current in myocardial muscle fibers. Pflugers Arch 307: 190–203
McDonald TF, Pelzer D, Trautwein W (1980) On the mechanism of slow calcium channel block in heart. Pflugers Arch 385: 175–179
Melville KI, Shister HE, Huq S (1964) Iproveratril: Experimental data on coronary dilation and antiarrhythmic action. Can Med Assoc J 90: 761–770
Nagao T, Matlib MA, Franklin D, Millard RW, Schwartz A (1980) Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion. J Mol Cell Cardiol 12: 29–43
Nakajima H, Hoshiyama M, Yamashita K, Kiyomoto A (1975) Effect of diltiazem on electrical and mechanical activity of isolated cardiac ventricular muscle of guinea pig. Jpn J Pharmacol 25: 383–392
Narimatsu a, taira N (1976) Effects on atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog. Naunyn-Schmiedebergs Arch Pharmacol 294: 169–177
Nawrath H, Ten Eick RE, McDonald TF, Trautwein W (1977) On the mechanism underlying the action of D 600 on slow inward current and tension in mammalian myocardium. Circ Res 40:408–414
Nayler WG, Grau A, Slade A (1976) A protective effect of verapamil on hypoxic heart muscle. Cardiovasc Res 10: 650–662
Refsum H (1975) Calcium-antagonistic and anti-arrhythmic effects of nifedipine on the isolated rat atrium. Acta Pharmacol Toxicol 37: 377–386
Refsum H, Landmark K (1975) The effect of a calcium-antagonistic drug, nifedipine, on the mechanical and electrical activity of the isolated rat atrium. Acta Pharmacol Toxicol 37: 369–376
Reuter H, Beeler GW (1969) Calcium current and activation of contraction in ventricular myocardial fibers. Science 162: 399–401
Späh F, Fleckenstein A (1979) Evidence of a new, preferentially Mg-carrying, transport system besides the fast Na and the slow Ca channels in the excited myocardial sarcolemma membrane. J Mol Cell Cardiol 11: 1109–1127
Späh F, Fleckenstein A (1980) Nachweis einer strengen, quantitativen Korrelation zwischen Hemmung des transmembranären Calcium-Influx und der mechanischen Spannungsentwicklung des Myocards unter dem Einfluß verschiedener Calcium-Antagonisten. In: Fleckenstein A, Roskamm H (Hrsg) Calcium-Antagonismus. Springer, Berlin Heidelberg New York, S 29–41
Späh F, Fleckenstein A (1981) The effects of calcium-antagonists, catecholamines, histamine and dibutyryl cyclic AMP on barium-induced ventricular automaticity. Pflugers Arch [Suppl] 389: R 8
Taira N, Motomura S, Narimatsu A, Iijima T (1975) Experimental pharmacological investigations of effects of nifedipine on atrioventricular conduction in comparison with those of other coronary vasodilators. In: Lochner W, Braasch W, Kroneberg G (eds) New therapy of ischemic heart disease, 2nd Internat. Adalat Symposium. Springer, Berlin Heidelberg New York, pp 40–48
Taira N, Narimatsu A (1975) Effects of nifedipine, a potent calcium-antagonistic coronary vasodilator, on atrioventricular conduction and blood flow in the isolated atrioventricular node preparation of the dog. Naunyn Schmiedebergs Arch Pharmacol 290: 107–112
Tritthart H, Fleckenstein B, Fleckenstein A (1970/71) Some fundamental actions of antiarrhythmic drugs on the excitability and the contractility of single myocardial fibres. Proceed. Joint Meeting of the Italian and German Pharmacol. Soc., Heidelberg, 27–30 Sept., 1970, Naunyn Schmiederbergs Arch Pharmacol 269: 212–21966. Tritthart H, Volkmann R, Weiss R, Fleckenstein A (1973) Calcium-mediated action potentials in mammalian myocardium. Alteration of membrane response as induced by changes of Cae or by promoters and inhibitors of transmembrane Ca inflow. Naunyn Schmiedebergs Arch Pharmacol 280: 239–252
Vassort G, Rougier O, Garnier D, Sauviat MP, Coraboeuf E, Gargouil YM (1969) Effects of adrenaline on membrane inward current during the cardiac action potential. Pflugers Arch 309: 70–81
Wit AL, Cranefield PF (1974) Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia. Circ Res 35: 413–425
Zipes DP, Fischer JC (1974) Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog. Circ Res 34: 184–192
Zipes DP, Mendez C (1973) Action of manganese and tetrodotoxin on atrioventricular nodal transmembrane potentials in isolated rabbit hearts. Circ Res 32: 447–454
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fleckenstein, A., Fleckenstein, B., Späh, F., Byon, Y.K. (1983). Gallopamil (D 600) — ein Kalziumantagonist von hoher Wirkungsstärke und Spezifität. Effekte auf Myokard und Schrittmacher. In: Kaltenbach, M., Hopf, R. (eds) Gallopamil. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69073-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-69073-0_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-12381-1
Online ISBN: 978-3-642-69073-0
eBook Packages: Springer Book Archive